Young biotech leader $IMCR with good VCP

Immunocore Holdings is a commercial-stage T cell receptor biotechnology company working to develop and commercialize transformative medicines for oncology, infectious diseases and autoimmune and inflammation diseases.

In a confirmed uptrend, yesterday signaled a good pivot buy where I placed an initial position.

I liked the volatility contraction pattern and the bullish divergence with the 10-day ROC prior to the breakout, and now I'll wait for the follow through action to add to the position.

Lets wait and see.
biotechbreakoutChart PatternsIMCRTechnical IndicatorsTrend Analysisuptrendvcppattern

Anche su:

Pubblicazioni correlate

Declinazione di responsabilità